Evidence map›Paper›PMID 35456057›Full record

ReviewPathogens (Basel, Switzerland)2022

Diagnostic Challenges in Childhood Pulmonary Tuberculosis-Optimizing the Clinical Approach.

Kenneth S Gunasekera, Bryan Vonasek, Jacquie Oliwa, Rina Triasih, Christina Lancioni, Stephen M Graham, James A Seddon, Ben J Marais

Open access · goldAbstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Asymptomatic Tuberculosis in Children With Household Exposure to Mycobacterium tuberculosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 8 institutions in 6 countries.

Kenneth S GunasekeraDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.ORCID 0000-0003-2098-2358
Bryan VonasekDepartment of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI 53726, USA.ORCID 0000-0002-5657-0980
Jacquie OliwaHealth Services Unit, KEMRI-Wellcome Trust Research Programme, Nairobi P.O. Box 43640-00100, Kenya.
Rina TriasihDepartment of Pediatrics, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada/Dr. Sardjito Hospital, Yogyakarta 55284, Indonesia.
Christina LancioniDepartment of Pediatrics, School of Medicine, Oregon Health and Science University, Portland, OR 97239, USA.
Stephen M GrahamCentre for International Child Health, University of Melbourne and Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, VIC 3052, Australia.ORCID 0000-0003-3525-2294
James A SeddonDepartment of Infectious Diseases, Imperial College London, London W2 1PG, UK.ORCID 0000-0002-2296-2302
Ben J MaraisUniversity of Sydney and The Children's Hospital at Westmead, Sydney, NSW 2145, Australia.
Desmond Tutu HIV Foundation · ZAOregon Health & Science University · USRoyal Children's Hospital · AUThe University of Sydney · AUUniversitas Gadjah Mada · IDUniversity of Nairobi · KEUniversity of Wisconsin–Madison · USYale University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
Eunice Kennedy Shriver National Institute of Child Health and Human Development F30HD105440Medical Research Council MR/R007942/1NIGMS NIH HHS T32GM007205
6 · The paper itself

Abstract

The management of childhood tuberculosis (TB) is hampered by the low sensitivity and limited accessibility of microbiological testing. Optimizing clinical approaches is therefore critical to close the persistent gaps in TB case detection and prevention necessary to realize the child mortality targets of the End TB Strategy. In this review, we provide practical guidance summarizing the evidence and guidelines describing the use of symptoms and signs in decision making for children being evaluated for either TB preventive treatment (TPT) or TB disease treatment in high-TB incidence settings. Among at-risk children being evaluated for TPT, a symptom screen may be used to differentiate children who require further investigation for TB disease before receiving TPT. For symptomatic children being investigated for TB disease, an algorithmic approach can inform which children should receive TB treatment, even in the absence of imaging or microbiological confirmation. Though clinical approaches have limitations in accuracy, they are readily available and can provide valuable guidance for decision making in resource-limited settings to increase treatment access. We discuss the trade-offs in using them to make TB treatment decisions.

Indexed as

childrendiagnosispaediatricsymptom-basedtuberculosis

Identifiers

PMID35456057
PMCPMC9032883
OpenAlexW4220816483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.